168 related articles for article (PubMed ID: 38609117)
21. NEIGHBOURING MELANOMAS AND DYSPLASTIC NEVUS DEVELOPING SIMULTANEOUSLY AFTER CANDESARTAN INTAKE: NITROSAMINE CONTAMINATION/ AVAILABILITY AS MAIN CAUSE FOR SKIN CANCER DEVELOPMENT AND PROGRESSION.
Tchernev G
Georgian Med News; 2023 Mar; (336):104-107. PubMed ID: 37166890
[TBL] [Abstract][Full Text] [Related]
22. А FLAVOUR OF DEATH: PERINDOPRIL INDUCED THICK MELANOMA AND BCC OF THE BACK. POTENTIAL ROLE OF THE GENERIC SUBSTANCE OR/-AND POSSIBLE NITROSAMINE CONTAMINATION AS SKIN CANCER KEY TRIGGERING FACTORS.
Tchernev G
Georgian Med News; 2023 Mar; (336):123-125. PubMed ID: 37166894
[TBL] [Abstract][Full Text] [Related]
23. Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA).
Kruhlak NL; Schmidt M; Froetschl R; Graber S; Haas B; Horne I; Horne S; King ST; Koval IA; Kumaran G; Langenkamp A; McGovern TJ; Peryea T; Sanh A; Siqueira Ferreira A; van Aerts L; Vespa A; Whomsley R
Regul Toxicol Pharmacol; 2024 Jun; 150():105640. PubMed ID: 38754805
[TBL] [Abstract][Full Text] [Related]
24. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
Reichrath J; Rass K
Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
[TBL] [Abstract][Full Text] [Related]
25. KARAPANDZIC FLAP FOR SQUAMOUS CELL CARCINOMA OF THE LOWER LIPP: POTENTIAL ROLE OF NITROSAMINES IN EPROSARTAN AS CANCER TRIGGERING FACTORS.
Tchernev G; Lozev I; Pidakev I; Kordeva S
Georgian Med News; 2023 Jan; (334):83-85. PubMed ID: 36864798
[TBL] [Abstract][Full Text] [Related]
26. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.
Rass K; Reichrath J
Adv Exp Med Biol; 2008; 624():162-78. PubMed ID: 18348455
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of ultraviolet radiation carcinogenesis.
Ananthaswamy HN; Pierceall WE
Photochem Photobiol; 1990 Dec; 52(6):1119-36. PubMed ID: 2087500
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous chemical carcinogenesis.
Yuspa SH
J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):1031-44. PubMed ID: 3537025
[TBL] [Abstract][Full Text] [Related]
29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency.
Snodin DJ; Trejo-Martin A; Ponting DJ; Smith GF; Czich A; Cross K; Custer L; Elloway J; Greene N; Kalgutkar AS; Stalford SA; Tennant RE; Vock E; Zalewski A; Ziegler V; Dobo KL
Chem Res Toxicol; 2024 Feb; 37(2):181-198. PubMed ID: 38316048
[TBL] [Abstract][Full Text] [Related]
31. [Apoptosis, UV-radiation, precancerosis and skin tumors].
Tomas D
Acta Med Croatica; 2009 Oct; 63 Suppl 2():53-8. PubMed ID: 19999548
[TBL] [Abstract][Full Text] [Related]
32. Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis.
Hecht SS
Proc Soc Exp Biol Med; 1997 Nov; 216(2):181-91. PubMed ID: 9349687
[TBL] [Abstract][Full Text] [Related]
33. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum.
Bodak N; Queille S; Avril MF; Bouadjar B; Drougard C; Sarasin A; Daya-Grosjean L
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5117-22. PubMed ID: 10220428
[TBL] [Abstract][Full Text] [Related]
34. Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s.
Li X; He X; Le Y; Guo X; Bryant MS; Atrakchi AH; McGovern TJ; Davis-Bruno KL; Keire DA; Heflich RH; Mei N
Arch Toxicol; 2022 Nov; 96(11):3077-3089. PubMed ID: 35882637
[TBL] [Abstract][Full Text] [Related]
35. Estimated Cancer Risks Associated with Nitrosamine Contamination in Commonly Used Medications.
Li K; Ricker K; Tsai FC; Hsieh CJ; Osborne G; Sun M; Marder ME; Elmore S; Schmitz R; Sandy MS
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574388
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients.
Couvé-Privat S; Le Bret M; Traiffort E; Queille S; Coulombe J; Bouadjar B; Avril MF; Ruat M; Sarasin A; Daya-Grosjean L
Cancer Res; 2004 May; 64(10):3559-65. PubMed ID: 15150112
[TBL] [Abstract][Full Text] [Related]
37. [Ultraviolet A-induced DNA damage: role in skin cancer].
Beani JC
Bull Acad Natl Med; 2014 Feb; 198(2):273-95. PubMed ID: 26263704
[TBL] [Abstract][Full Text] [Related]
38. Ultraviolet radiation and cutaneous carcinogenesis.
Molho-Pessach V; Lotem M
Curr Probl Dermatol; 2007; 35():14-27. PubMed ID: 17641487
[TBL] [Abstract][Full Text] [Related]
39. Permitted daily exposure limits for noteworthy N-nitrosamines.
Johnson GE; Dobo K; Gollapudi B; Harvey J; Kenny J; Kenyon M; Lynch A; Minocherhomji S; Nicolette J; Thybaud V; Wheeldon R; Zeller A
Environ Mol Mutagen; 2021 Jun; 62(5):293-305. PubMed ID: 34089278
[TBL] [Abstract][Full Text] [Related]
40. Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity data.
Thresher A; Foster R; Ponting DJ; Stalford SA; Tennant RE; Thomas R
Regul Toxicol Pharmacol; 2020 Oct; 116():104749. PubMed ID: 32777431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
